Form D · Pharmaceuticals
ProstaGene, LLC
Wynnewood, PA · CIK 0001635915
Offering snapshot reported Apr 20, 2016 · SEC filing
- Reported sold
- $400K Offering amount: $1.4M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Apr 8, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 20, 2016 | Initial | $400,000 | No comparison | 4 | SEC filing |
| May 19, 2015 | Amendment | $825,000 | $425,000vs Mar 10, 2015 | 6 | SEC filing |
| Mar 10, 2015 | Initial | $400,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-261746
Source: Form D, filed Apr 20, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dan Matthias | Director, Executive |
| Richard Pestell | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 East Lancaster Avenue #133
Wynnewood, PA, 19096
Wynnewood, PA, 19096